By boosting ROS generation, which is crucial in the development of IBD, interleukins (IL-1 and IL-6) and tumor necrotic factor-alpha (TNF-α) lessen the intensity of inflammation (Lu and Zhao, 2020). This evidence concerns the gene TNF and inflammatory bowel disease.